Increase of peroxisome proliferator-activated receptor δ gene expression in the lungs of streptozotocin-induced diabetic rats

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 1, 2007, Pages 69-74

  Huang, Chang Jer ^a   Liu, I Min ^b   Cheng, Juei Tang ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Lung; Phlorizin; PPAR ; STZ diabetic rats

Indexed keywords

GLUCOSE; INSULIN; INSULIN ZINC SUSPENSION; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHLORIZIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA TRANSCRIPTION; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BLOTTING, NORTHERN; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAPERITONEAL; INSULIN, LONG-ACTING; LUNG; MALE; PHLORHIZIN; PPAR DELTA; RATS; RATS, WISTAR; RNA, MESSENGER; STREPTOZOCIN;

EID: 33751049864     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2005.11.012     Document Type: Article

References (20)

1. Koh G., Suh K.S., Chon S., Oh S., Woo J.T., Kim S.W., et al. Elevated cAMP level attenuates 2-deoxy-d-ribose-induced oxidative damage in pancreatic beta-cells. Arch Biochem Biophys 438 (2005) 70-79
2. Sugawara I., Yamada H., and Mizuno S. Pulmonary tuberculosis in spontaneously diabetic goto kakizaki rats. Tohoku J Exp Med 204 (2004) 135-145
3. Popov D., and Simionescu M. Structural and transport property alterations of the lung capillary endothelium in diabetes. Ital J Anat Embryol 106 2 Suppl 1 (2001) 405-412
4. Berger J.P., Akiyama T.E., and Meinke P.T. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 26 (2005) 244-251
5. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPARα, -β and -γ in the adult rat. Endocrinology 137 (1996) 354-366
6. Tzameli I., Fang H., Ollero M., Shi H., Hamm J.K., Kievit P., et al. Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem 279 (2004) 36093-36102
7. Patel H.J., Belvisi M.G., Bishop-Bailey D., Yacoub M.H., and Mitchell J.A. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J Immunol 170 (2003) 2663-2669
8. 2 mediates peroxisome proliferator-activated receptor-γ activation in human lung epithelial cells. : J Biol Chem 277 (2002) 33153-33163
9. Serhan C.N. Inflammation. Signalling the fat controller. Nature 384 (1996) 23-24
10. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393 (1998) 790-793
11. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J.M., Gonzalez F.J., et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274 (1999) 32048-32054
12. Jiang C., Ting A.T., and Seed B. PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
13. Wang A.C., Dai X., Luu B., and Conrad D.J. Peroxisome proliferator-activated receptor-γ regulates airway epithelial cell activation. Am J Respir Cell Mol Biol 24 (2001) 688-693
14. Xing G., Zhang L., Zhang L., Heynen T., Yoshikawa T., Smith M., et al. Rat PPARδ contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochem Biophys Res Commun 217 (1995) 1015-1025
15. Liu I.M., Tzeng T.F., Tsai C.C., Lai T.Y., Chang C.T., and Cheng J.T. Increase in adenosine A1 receptor gene expression in the liver of streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 19 (2003) 209-215
16. Takada I., Yu R.T., Xu H.E., Lambert M.H., Montana V.G., Kliewer S.A., et al. Alteration of a single amino acid in peroxisome proliferator-activated receptor-alpha (PPARα) generates a PPARδ phenotype. Mol Endocrinol 14 (2000) 733-740
17. Rossetti L., Smith D., Shulman G.I., Papachristou D., and De Fronzo R.A. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79 (1987) 1510-1515
18. Wang Y.X., Lee C.H., Tiep S., Yu R.T., Ham J., Kang H., et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113 (2003) 159-170
19. Wang Y.X., Zhang C.L., Yu R.T., Cho H.K., Nelson M.C., Bayuga-Ocampo C.R., et al. Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol 2 (2004) 1532-1539
20. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 53 (2002) 409-435